科蓝软件(300663.SZ)披露定增报告:最终获配投资者共13家 嘉实基金在内
格隆汇 11 月 11日丨科蓝软件(300663.SZ)披露非公开发行股票新增股份变动报告及上市公告书,发行人和联席主承销商根据本次发行的股份配售规则以及有效认购的簿记建档情况,对有效认购对象进行配售。此次发行最终获配投资者共13家,发行价格为24.05元/股,此次发行股票数量为1313.9287万股,募集资金总额约3.16亿元。各发行对象获得配售的情况如下:

此次发行完成后,公司新增股份1313.9287万股,将于2020年11月17日在深圳证券交易所创业板上市。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.